The Body That Won’t Eat — and the Body That Won’t Stop Storing: Food, Weight, and ME/CFS
There is a story that clinicians sometimes tell about ME/CFS patients who stop eating. The story goes: she is a teenage girl, she is losing weight, she is refusing food, she must have an eating disorder.
The story is sometimes wrong. And when it is wrong, the consequences are serious.
1 Why ME/CFS patients stop eating
Eating difficulties affect roughly 10% of adolescents with ME/CFS, and over half experience significant nausea or abdominal pain. The avoidance is not psychological — the mechanisms are organic, and they compound each other.
Large meals, heavy foods, even the effort of sitting upright long enough to finish a plate can push a patient past their energy threshold and trigger a delayed crash. Food becomes associated with worsening, not irrationally but accurately. Studies using ultrasound drink tests have documented visceral hypersensitivity and impaired gastric accommodation in ME/CFS patients: the stomach does not expand normally to receive food, and the nerves in the gut wall are hypersensitive. Upper abdominal pain and nausea worsen measurably in the minutes after eating, by the same mechanism as functional dyspepsia.
Meanwhile, pro-inflammatory signaling molecules — GDF-15, IL-6, TNF-α — act on appetite centers in the brain and reduce hunger independently of any psychological state. This is sickness behavior: the same evolved mechanism that makes you not want to eat when you have the flu, except in ME/CFS it does not switch off. The anorexia is immunological, not psychiatric. And in very severe cases, chewing, swallowing, and sitting upright are not trivial acts — they are energy expenditures. For a patient whose available energy for an entire day is equivalent to what a healthy person uses in a single hour, a meal is not a small thing.
2 The misdiagnosis that costs lives
When a teenage girl with ME/CFS loses significant weight because she cannot eat without crashing, a clinician unfamiliar with ME/CFS may see the following: female patient, weight loss, food avoidance, fatigue. The differential that comes to mind is anorexia nervosa.
This misdiagnosis is documented. It has specific, serious consequences.
Nutritional support — including tube feeding — is withheld while teams pursue psychiatric explanations. Standard eating disorder treatments are applied: behavioral activation, graded exposure to feared foods, motivational enhancement targeting the “refusal” to eat. These interventions assume the patient’s restriction is volitional and that the solution is psychological. When the restriction is organic, they fail. Worse: behavioral activation risks triggering post-exertional malaise in a patient who is already severely ill.
In 2021, Baxter, Speight, and Weir published a case series in Healthcare documenting five patients with very severe ME/CFS who became life-threateningly malnourished (Baxter, Speight, and Weir 2021). In every case, the delay was caused by clinician hesitation — teams “postulating psychological theories” rather than addressing a primary medical need. The consequences included neurological damage, osteoporosis, cardiac complications, poor wound healing.
The distinguishing features that should prevent this misdiagnosis are clear once you know to look for them. A patient with ME/CFS-driven eating difficulty is distressed by her inability to eat. She wants to eat normally. She does not have body image distortion. Her weight loss is not desired — it is lamented. Her eating difficulty tracks her disease severity, worsening during flares and improving when the disease improves. She has objective signs of ME/CFS: orthostatic intolerance on tilt testing, post-exertional malaise documented over days, the specific signature of this disease.
The patient with anorexia nervosa presents differently in nearly every dimension.
3 The opposite problem: weight gain that doesn’t respond to the usual advice
The eating story in ME/CFS runs in both directions.
For patients who can eat, involuntary weight gain is common. The mechanisms are straightforward: near-total physical inactivity imposed by the disease, slowed metabolism, disrupted hormonal regulation. What is less obvious — and clinically important — is the specific pattern of weight change that occurs.
ME/CFS is associated with approximately a doubling of the risk of metabolic syndrome: elevated waist circumference, high triglycerides, elevated fasting glucose, reduced HDL. The relationship is dose-dependent — in a population-based case-control study, each additional metabolic syndrome component was associated with a 37% increase in the odds of ME/CFS diagnosis.
More striking is a pattern called sarcopenic obesity: fat mass increases while muscle mass decreases, even in patients whose total body weight looks normal. The mechanisms converge from several directions. The body cannot burn fat efficiently — studies have identified specific deficits in the enzymes that oxidize fatty acids (ACAD and CPT), meaning stored fat accumulates rather than being used as fuel. Simultaneously, muscle protein synthesis is impaired because the mitochondrial dysfunction that causes fatigue also impairs the energy-dependent process of building and maintaining muscle. Skeletal muscle abnormalities in ME/CFS — atrophy, reduced oxidative capacity, altered fiber composition — have been documented histologically.
The result: a patient who may look “normal weight” on a scale but whose body composition has shifted significantly toward fat and away from muscle. Standard BMI measurements miss this entirely.
4 Why standard advice fails here
“Lose weight through diet and exercise.” For most conditions associated with obesity, this is reasonable guidance. For ME/CFS, it is contraindicated.
Exercise-based weight management triggers post-exertional malaise. NICE withdrew its recommendation for graded exercise therapy in ME/CFS in 2021 based on evidence of harm from patient surveys and trial re-analyses — and the same mechanism applies regardless of whether the goal is rehabilitation or weight management. Prescribing progressive exercise to reduce body fat in ME/CFS follows the same path that causes crashes and worsening; the destination does not change the consequences.
Caloric restriction without careful attention to nutrient density compounds the nutritional deficits already present. ME/CFS patients frequently have deficiencies in B vitamins, magnesium, zinc, vitamin D, and omega-3 fatty acids — nutrients that support mitochondrial function and immune regulation. Restricting calories without addressing micronutrient density starves already-impaired metabolic processes of essential cofactors.
The medical framing of “just lose weight” also ignores why the weight is there. The fat accumulation in ME/CFS is not a behavioral problem. It is a consequence of impaired fat oxidation, enforced inactivity, and disrupted metabolic regulation. Addressing it requires addressing those upstream causes — not simply reducing calories or increasing movement.
5 Appetite regulation gone wrong
Appetite regulation is not simply a matter of willpower or habit; it is mediated by hormones and immune signals, and ME/CFS disrupts several of them.
Leptin is the hormone that tells the brain “you have enough fat stores, stop eating.” Studies have found elevated circulating leptin in the insulin-resistant ME/CFS subtype — paradoxically high, given that high leptin should suppress appetite and fat storage. The pattern is consistent with leptin resistance, where the brain no longer responds adequately to the signal, a known consequence of chronic inflammation. Fat continues to accumulate despite the signal that should prevent it.
AMPK adds another layer of disruption. It is the cell’s primary energy sensor, activated when cellular ATP falls, which in ME/CFS it chronically does. AMPK normally drives hunger and promotes fat oxidation. But when the downstream fat oxidation machinery is itself broken, the signal is generated without the intended response: the patient is hungry, or ought to be hungry, but eating does not resolve the cellular energy crisis because the problem is not lack of food — it is the inability to convert food into energy.
6 What actually helps
The evidence base for nutritional intervention in ME/CFS is thin but the principles are clear. Small, frequent meals reduce the energy expenditure of any single eating event and reduce postprandial orthostatic stress. Low-glycemic-index carbohydrates — oats, rice, potato — help stabilize blood glucose without triggering large insulin spikes that may worsen insulin resistance, and adequate protein slows the muscle wasting associated with inactivity. Dietitian involvement is essential; unguided dietary restriction in ME/CFS carries a documented risk of serious nutritional deficiency.
For patients who cannot maintain adequate intake orally, enteral nutrition — nasogastric or nasojejunal tube feeding — is sometimes necessary and should not be delayed. The decision to initiate tube feeding in ME/CFS is a medical decision, not a psychiatric one. Waiting for a psychiatric assessment before feeding a malnourished patient is not standard of care — it is a failure of care.
7 The larger picture
ME/CFS disrupts eating from both ends simultaneously. Some patients cannot eat enough. Others cannot stop their bodies from changing composition in ways that feel beyond their control. Both groups face an added layer of stigma: the patient who is thin is assumed to have an eating disorder; the patient who is overweight is assumed not to be trying hard enough.
Neither assumption is appropriate, and both miss the underlying biology.
The food problem in ME/CFS is a metabolic, immunological, and neurological problem — wearing the clothes of something more familiar and more convenient to dismiss.